The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors
Author:
Funder
UKRI Medical Research Council
Publisher
Elsevier BV
Reference124 articles.
1. Kymriah® (tisagenlecleucel) - an overview of the clinical development journey of the first approved CAR-T therapy;Awasthi;Hum Vaccin Immunother,2023
2. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome;Liu;Sci Immunol,2020
3. Learning from TCR signaling and immunological synapse assembly to bulid new chimeric antigen receptors (CARs);Cassioli;Int. J. Mol. Sci.,2022
4. Glycan-directed CAR-T cells;Steentoft;Glycobiology,2018
5. The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28;Muller;Front. Immunol.,2021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09
2. First report: PLATFORM study for precision treatment of rare tumors in China;Cancer Letters;2024-08
3. Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells;Sechenov Medical Journal;2024-07-31
4. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04
5. Engraftment of a Surrogate Antigen Onto Tumor Cell Surface Via Phlip Peptide to Universally Target Car-T Cell Therapy to Solid Tumors;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3